We review the 2024 performance of both assets, the 2025 outlook, and some specific recommendations for investment in shares ...

Investing $1,000 a month with an average total return of 12% per annum would grow into $2.15 million after 27 years. That ...

Last week, the broker reaffirmed its buy rating and $40.20 price target on the ASX 200 share. This implies potential upside ...

Let's run the numbers and see how much an Australian investor would need in their superannuation fund to live off $65,000 a ...

Up 25% in 12 months, a leading fundie sees strong ongoing growth potential for this S&P/ASX 300 Index (ASX: XKO) stock.

The S&P/ASX 200 Index (ASX: XJO) is up 3% in 2025, with these three ASX 200 stocks doing a lot of the heavy lifting.

Kogan.com Ltd (ASX: KGN) and Regis Resources Ltd (ASX: RRL) are two of four ASX shares falling on Friday. Here's ...

This S&P/ASX 300 Index (ASX: XKO) tech stock has delivered by strong returns in the last few years. Here’s why there could be ...

The All Ordinaries Index (ASX: XAO) is up 0.32% today, but this ASX share is leaving those gains in the dust. Here’s what’s ...

ASX healthcare stocks are in the green on Friday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) currently 0.41% higher.

The AMP Ltd (ASX: AMP) share price just leapt to new multi-year highs. Here’s what’s happening with the ASX 200 financial ...

Goldman has a buy rating and $40.20 price target on its shares. Another ASX 200 share that is being described as a fallen ...